Evoke plc (LON:EVOK – Get Free Report)’s share price was down 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
Several analysts recently commented on EVOK shares. Berenberg Bank cut their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th. Jefferies Financial Group reissued a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th.
View Our Latest Stock Report on EVOK
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last released its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Equities analysts expect that Evoke plc will post 12.7648305 EPS for the current year.
Insider Transactions at Evoke
In other Evoke news, insider Andrea Gisle Joosen acquired 14,572 shares of the stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
About Evoke
See Also
- Five stocks we like better than Evoke
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- MarketBeat Week in Review – 03/24 – 03/28
- How to Profit From Value Investing
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Does a Stock Split Mean?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.